A Clinical and Molecular Survey of 62 Cystic Fibrosis Patients from Umbria (Central Italy) Disclosing a High Frequency (2.4%) of the 2184insA Allele: Implications for Screening

Publisher： Karger

E-ISSN： 1662-8063|19|6|336-341

ISSN： 1662-4246

Source： Public Health Genomics, Vol.19, Iss.6, 2016-10, pp. : 336-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carrier Testing Program in a High-Risk Cystic Fibrosis Population from Northeastern Italy

By  

Public Health Genomics, Vol. 2, Iss. 2-3, 2000-03 ,pp. : 82-90

Karger

Access to resources Recommend Favorite

Cystic fibrosis: A look into the future of prenatal screening and therapy

By  

Birth Defects Research. Part C: Embryo Today Reviews, Vol. 105, Iss. 1, 2015-03 ,pp. : 73-80

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is Cystic Fibrosis Carrier Screening Cost Effective?

By  

Public Health Genomics, Vol. 10, Iss. 2, 2007-03 ,pp. : 103-109

Karger

Access to resources Recommend Favorite

Assessing the Potential Success of Cystic Fibrosis Carrier Screening: Lessons Learned from Tay-Sachs Disease and β-Thalassemia

By  

Public Health Genomics, Vol. 13, Iss. 5, 2009-10 ,pp. : 310-319

Karger

Access to resources Recommend Favorite

Analysis of the Polymorphic Markers within the CFTR Gene in Cystic Fibrosis Patients and Healthy Donors from Bashkortostan

By Korytina G. F.   Victorova T. V.   Ivashchenko T. E.   Baranov V. S.   Khusnutdinova E. K.  

Russian Journal of Genetics, Vol. 39, Iss. 11, 2003-11 ,pp. : 1306-1312

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite